Clinical Trials Logo

Familial Combined Hyperlipidemia clinical trials

View clinical trials related to Familial Combined Hyperlipidemia.

Filter by:
  • None
  • Page 1

NCT ID: NCT02130505 Completed - Clinical trials for Type 2 Diabetes Mellitus

Inflammatory Aspects of Glucose in Hyperlipidemia and Diabetes

INFORM
Start date: June 2007
Phase: N/A
Study type: Interventional

In this study, we will investigate both inflammatory systems in healthy volunteers and patients with T2DM on insulin therapy and hyperlipidemia (both familial hyperlipidemia (FH) and familial combined hyperlipidemia (FCH)) during an OGTT.

NCT ID: NCT00465751 Completed - Metabolic Syndrome Clinical Trials

Effects of FXR Activation on Hepatic Lipid and Glucose Metabolism

Start date: October 2004
Phase: Phase 0
Study type: Interventional

The purpose of this study is to determine whether chenodeoxycholic acid decreases de novo hepatic lipogenesis, hepatic fat content, hepatic triglyceride production and plasma triglyceride concentrations and improves hepatic glucose metabolism in patients with the metabolic syndrome, Familial Hypertriglyceridemia and Familial Combined Hyperlipidemia.